
Jennifer E. Graser
Examiner (ID: 2460)
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1802, 1645, 1641, 1621 |
| Total Applications | 1924 |
| Issued Applications | 1280 |
| Pending Applications | 238 |
| Abandoned Applications | 464 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10953368
[patent_doc_number] => 20140356390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-04
[patent_title] => 'MODULATION OF REPLICATIVE FITNESS BY DEOPTIMIZATION OF SYNONYMOUS CODONS'
[patent_app_type] => utility
[patent_app_number] => 14/464619
[patent_app_country] => US
[patent_app_date] => 2014-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 63
[patent_figures_cnt] => 63
[patent_no_of_words] => 42682
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14464619
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/464619 | MODULATION OF REPLICATIVE FITNESS BY DEOPTIMIZATION OF SYNONYMOUS CODONS | Aug 19, 2014 | Abandoned |
Array
(
[id] => 11009768
[patent_doc_number] => 20160206721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'BACTERIAL VACCINE AND METHODS FOR MANUFACTURE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/913816
[patent_app_country] => US
[patent_app_date] => 2014-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 13353
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14913816
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/913816 | Bacterial vaccine and methods for manufacture thereof | Aug 18, 2014 | Issued |
Array
(
[id] => 10953866
[patent_doc_number] => 20140356886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-04
[patent_title] => 'METHOD FOR MEASURING BETA-GLUCAN, AND BETA-GLUCAN-BINDING PROTEIN FOR USE IN THE METHOD'
[patent_app_type] => utility
[patent_app_number] => 14/459020
[patent_app_country] => US
[patent_app_date] => 2014-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 34054
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14459020
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/459020 | METHOD FOR MEASURING BETA-GLUCAN, AND BETA-GLUCAN-BINDING PROTEIN FOR USE IN THE METHOD | Aug 12, 2014 | Abandoned |
Array
(
[id] => 10183350
[patent_doc_number] => 09213026
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-15
[patent_title] => 'System for determining unprocessed and partially processed neurotoxin type A'
[patent_app_type] => utility
[patent_app_number] => 14/458514
[patent_app_country] => US
[patent_app_date] => 2014-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8984
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 216
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14458514
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/458514 | System for determining unprocessed and partially processed neurotoxin type A | Aug 12, 2014 | Issued |
Array
(
[id] => 11177969
[patent_doc_number] => 09409955
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-09
[patent_title] => 'Microbial nanowires'
[patent_app_type] => utility
[patent_app_number] => 14/448843
[patent_app_country] => US
[patent_app_date] => 2014-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 31
[patent_no_of_words] => 30149
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14448843
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/448843 | Microbial nanowires | Jul 30, 2014 | Issued |
Array
(
[id] => 10974266
[patent_doc_number] => 20140377301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'Vault Compositions for Immunization'
[patent_app_type] => utility
[patent_app_number] => 14/341782
[patent_app_country] => US
[patent_app_date] => 2014-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15761
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14341782
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/341782 | Vault compositions for immunization | Jul 25, 2014 | Issued |
Array
(
[id] => 11508455
[patent_doc_number] => 09599607
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-21
[patent_title] => 'Potency test for vaccine formulations'
[patent_app_type] => utility
[patent_app_number] => 14/320840
[patent_app_country] => US
[patent_app_date] => 2014-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5641
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14320840
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/320840 | Potency test for vaccine formulations | Jun 30, 2014 | Issued |
Array
(
[id] => 12343599
[patent_doc_number] => 09950030
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-24
[patent_title] => Treatment and diagnosis of ocular disease
[patent_app_type] => utility
[patent_app_number] => 14/901631
[patent_app_country] => US
[patent_app_date] => 2014-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 7943
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14901631
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/901631 | Treatment and diagnosis of ocular disease | Jun 26, 2014 | Issued |
Array
(
[id] => 11311730
[patent_doc_number] => 20160347841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-01
[patent_title] => 'NEW MONOCLONAL ANTIBODIES AGAINST THE RECEPTOR DEC-205 OF CHICKEN DENTRITIC CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/898037
[patent_app_country] => US
[patent_app_date] => 2014-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9233
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14898037
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/898037 | Monoclonal antibodies against the DEC-205 receptor of chicken dendritic cells | Jun 16, 2014 | Issued |
Array
(
[id] => 9864230
[patent_doc_number] => 20150044249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-12
[patent_title] => 'POLYVALENT CHIMERIC OSPC VACCINOGEN AND DIAGNOSTIC ANTIGEN'
[patent_app_type] => utility
[patent_app_number] => 14/299211
[patent_app_country] => US
[patent_app_date] => 2014-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 34113
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14299211
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/299211 | Polyvalent chimeric OspC vaccinogen and diagnostic antigen | Jun 8, 2014 | Issued |
Array
(
[id] => 10905721
[patent_doc_number] => 20140308734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-16
[patent_title] => 'PROTEINS WITH REPETITIVE BACTERIAL-IG-LIKE (BIG) DOMAINS PRESENT IN LEPTOSPIRA SPECIES'
[patent_app_type] => utility
[patent_app_number] => 14/281580
[patent_app_country] => US
[patent_app_date] => 2014-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12060
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14281580
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/281580 | Proteins with repetitive bacterial-Ig-like (Big) domains present in Leptospira species | May 18, 2014 | Issued |
Array
(
[id] => 10761953
[patent_doc_number] => 20160108106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-21
[patent_title] => 'GENERATION OF HIGHLY POTENT ANTIBODIES NEUTRALIZING THE LUKGH (LUKAB) TOXIN OF STAPHYLOCOCCUS AUREUS'
[patent_app_type] => utility
[patent_app_number] => 14/892925
[patent_app_country] => US
[patent_app_date] => 2014-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 18095
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14892925
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/892925 | GENERATION OF HIGHLY POTENT ANTIBODIES NEUTRALIZING THE LUKGH (LUKAB) TOXIN OF STAPHYLOCOCCUS AUREUS | May 15, 2014 | Abandoned |
Array
(
[id] => 10728345
[patent_doc_number] => 20160074494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-17
[patent_title] => 'CANCER THERAPY'
[patent_app_type] => utility
[patent_app_number] => 14/785579
[patent_app_country] => US
[patent_app_date] => 2014-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9262
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14785579
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/785579 | CANCER THERAPY | May 8, 2014 | Abandoned |
Array
(
[id] => 10799168
[patent_doc_number] => 20160145325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'AGROCHEMICAL COMPOSITIONS COMPRISING ANTIBODIES BINDING TO SPHINGOLIPIDS'
[patent_app_type] => utility
[patent_app_number] => 14/787454
[patent_app_country] => US
[patent_app_date] => 2014-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 46432
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14787454
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/787454 | AGROCHEMICAL COMPOSITIONS COMPRISING ANTIBODIES BINDING TO SPHINGOLIPIDS | Apr 28, 2014 | Abandoned |
Array
(
[id] => 10743278
[patent_doc_number] => 20160089429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-31
[patent_title] => 'ORAL VACCINE HAVING IMPROVED CELLULAR IMMUNITY INDUCTION POTENCY'
[patent_app_type] => utility
[patent_app_number] => 14/785364
[patent_app_country] => US
[patent_app_date] => 2014-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6705
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14785364
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/785364 | Oral vaccine having improved cellular immunity induction potency | Apr 17, 2014 | Issued |
Array
(
[id] => 11929778
[patent_doc_number] => 09796762
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-24
[patent_title] => 'Polypeptide and immune modulation'
[patent_app_type] => utility
[patent_app_number] => 14/249710
[patent_app_country] => US
[patent_app_date] => 2014-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 63
[patent_figures_cnt] => 27
[patent_no_of_words] => 68882
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14249710
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/249710 | Polypeptide and immune modulation | Apr 9, 2014 | Issued |
Array
(
[id] => 11929778
[patent_doc_number] => 09796762
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-24
[patent_title] => 'Polypeptide and immune modulation'
[patent_app_type] => utility
[patent_app_number] => 14/249710
[patent_app_country] => US
[patent_app_date] => 2014-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 63
[patent_figures_cnt] => 27
[patent_no_of_words] => 68882
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14249710
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/249710 | Polypeptide and immune modulation | Apr 9, 2014 | Issued |
Array
(
[id] => 10700552
[patent_doc_number] => 20160046699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-18
[patent_title] => 'PEPTIDES AND BINDING PARTNERS THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 14/783237
[patent_app_country] => US
[patent_app_date] => 2014-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8899
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14783237
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/783237 | Peptides and binding partners therefor | Apr 9, 2014 | Issued |
Array
(
[id] => 12198585
[patent_doc_number] => 09901633
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-27
[patent_title] => 'Immunogenic complex for vaccination and method for the production thereof'
[patent_app_type] => utility
[patent_app_number] => 14/781733
[patent_app_country] => US
[patent_app_date] => 2014-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 45
[patent_no_of_words] => 16856
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14781733
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/781733 | Immunogenic complex for vaccination and method for the production thereof | Apr 2, 2014 | Issued |
Array
(
[id] => 12212317
[patent_doc_number] => 09909114
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-06
[patent_title] => 'Vaccines comprising leishmania polypeptides for the treatment and diagnosis of leishmaniasis'
[patent_app_type] => utility
[patent_app_number] => 14/780504
[patent_app_country] => US
[patent_app_date] => 2014-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 7
[patent_no_of_words] => 31140
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14780504
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/780504 | Vaccines comprising leishmania polypeptides for the treatment and diagnosis of leishmaniasis | Mar 27, 2014 | Issued |